(19)
(11) EP 0 359 919 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
03.10.1990 Bulletin 1990/40

(43) Date of publication A2:
28.03.1990 Bulletin 1990/13

(21) Application number: 89111748.3

(22) Date of filing: 28.06.1989
(51) International Patent Classification (IPC)5: C12N 15/31, A61K 39/02, C12N 1/21, C07K 14/30, C12P 21/02
// C12N1:21, C12R1:19
(84) Designated Contracting States:
AT BE CH DE ES FR GB GR IT LI LU NL SE

(30) Priority: 29.06.1988 US 213248
07.04.1989 US 334586
21.04.1989 US 341968

(71) Applicant: ML TECHNOLOGY VENTURES, L.P.
New York New York 10080 (US)

(72) Inventors:
  • Faulds, Daryl H.
    California (US)
  • Brooks, Emily
    California (US)
  • Andrews, William H.
    California (US)
  • Lory, Carol
    California (US)

(74) Representative: Perry, Robert Edward et al
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)


(56) References cited: : 
   
       


    (54) Recombinant mycoplasma hyopneumoniae antigen and uses therefor


    (57) Gentically Engineered M. hyo antigen; in particular the 74.5 kDa; or 41 kDa, or 36 kDa; or 96 kDa; or 41* kDa antigen, and mutations thereof. The antigens can be used as vaccines or diagnostics.







    Search report